Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID06801821

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-08-26

400

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating how the general population emotionally reacts to facial involvement in four major skin diseases: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. The study aims to compare social distance and stereotyping toward individuals with these conditions and to identify demographic factors linked to a higher tendency to stigmatize. This observational research focuses on understanding stigma associated with these dermatologic diseases. Participants will view images of faces affected by atopic dermatitis, alopecia areata, vitiligo, and psoriasis, created through artificial intelligence. They will select which face evokes feelings such as compassion, disgust, blame, or curiosity. Each participant will then complete a 14-question stigma survey related to one of the four diseases, randomly assigned. Responses are scored on a 1 to 5 Likert scale, measuring social distance and stereotyping. During the study, basic demographic information like age, gender, employment, and education will be collected. The research team will analyze emotional responses and stigma scores to assess attitudes in the general population. The main outcome will be evaluated after 12 months. The total participation time and follow-up details are based on this 12-month endpoint, with no treatments or interventions involved.

CONDITIONS

Brief Title

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged over 18 years, both sexes
  • Signed written informed consent
Not Eligible

You will not qualify if you...

  • Patients diagnosed with psoriasis, atopic dermatitis, vitiligo, or alopecia areata
  • Patients with first-degree relatives with psoriasis, atopic dermatitis, vitiligo, or alopecia areata
  • Those with professional or personal direct knowledge of these diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Observational Assessment

Duration - Single session

Participants observe images depicting faces of individuals with specific skin conditions and complete a 14-question questionnaire on stigma toward one of the diseases under investigation.

1 visit (in-person or remote)

Long-term Monitoring

Duration - 12 months

Participants' responses are analyzed up to 12 months after the initial assessment to evaluate stigma over time.

No additional visits required

Trial Site Locations

Total: 1 location

1

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia

Roma, Italia, Italy, 00168

Actively Recruiting

Loading map...

Research Team

C

Caldarola

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dos...

Atopic Dermatitis

Actively Recruiting

1 location

A Multicenter, Randomized, Double-Blind, Placebo-Controlled,...

Atopic Dermatitis

Actively Recruiting

64 locations

A Double-Blind, Randomized, Vehicle-Controlled Study to Asse...

Eczema Atopic Dermatitis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here